Ablation monitoring system and method
The ultrasound catheter system with pulse-echo techniques and EM navigation addresses the challenge of accurately measuring ice spheres during cryosurgery, enabling precise 3D modeling and real-time adjustment for effective tissue ablation.
Patent Information
- Application Number
- JP2024131742
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-08-21
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-13
- Estimated Expiration
- 2040-08-17
AI Technical Summary
Existing ultrasound imaging techniques cannot accurately measure the true size, shape, and location of ice balls formed during cryosurgery due to the reflective properties of ice, which create an acoustic shadow, preventing penetration and visualization of the ice sphere's interior.
An ultrasound catheter system with an annular array of transducers is used to emit and receive ultrasound signals, employing pulse-echo techniques and beamforming to calculate the ice sphere's dimensions by measuring the time of signal reflection, combined with EM navigation for precise positioning, allowing for a 3D model of the ice sphere to be superimposed on preoperative CT images.
Enables accurate measurement and visualization of the ice sphere's size and shape, ensuring complete ablation of target tissue while minimizing damage to surrounding healthy tissue, and providing real-time feedback for adjusting treatment as needed.
Smart Images

Figure 2024160314000001_ABST
Abstract
Description
FIELD OF THEINVENTION
[0001] A medical device, ultrasound catheter system and method is provided that allows for the measurement of ice ball size, shape and location during cryosurgery. Similar systems and methods can be used to measure the size, shape and location of tissue that is to be thermally ablated. [Background technology]
[0002] Cryosurgery, or cryoablation, is a technique in which abnormal or targeted tissue is destroyed by freezing. Freezing of tissue cells results in the destruction of the cells or organelles within the cells. The cryosurgery process requires the insertion of a device (a "cryoprobe") into the abnormal tissue, which is then cooled. In most cases, cooling of the cryoprobe is accomplished by passing a high-pressure gas, such as argon, through the device. Cooling the cryoprobe in this manner results in the formation of an "ice ball" of frozen tissue that is approximately centered at the distal end of the cryoprobe.
[0003] Precise measurement of the size, shape and position of the ice ball is crucial to the success of this technique: if the ice ball is too large, it will unnecessarily damage healthy tissue surrounding the target tissue, and if it is too small, abnormal tissue will survive the process.
[0004] Traditionally, ice ball size and location have been measured by ultrasound techniques. Ultrasound energy penetrates healthy tissue and then impacts the outer surface of the ice ball. Due to the properties of the ice ball, the ultrasound energy typically bounces off the ice ball. This large reflection allows ultrasound imaging techniques to image the surface of the ice ball closest to the source of ultrasound energy. However, ultrasound energy cannot penetrate the ice ball and the "shadow" cast by this surface reflection does not allow an image of the true three-dimensional size and shape of the ice ball. Essentially, existing methods allow a user to find the approximate location of the closest surface of the ice ball, but are unable to determine its true size, shape, or location. Summary of the Invention
[0005] One embodiment of the present invention provides a method of treating a tumor or other target tissue using cryoablation. The method begins with locating the target tissue, such as by performing a CT image acquisition prior to the ablation procedure. The image formed may be incorporated into a 3D image or a 3D model of the patient or patient's organ. An ultrasound catheter contained within a guiding cannula is inserted into the target tissue during the ablation procedure. In one embodiment, the ultrasound catheter and cannula are inserted percutaneously. Once in position, the ultrasound catheter can be used to image the target tissue to ensure proper positioning of the catheter and cannula. The ultrasound catheter may allow for QUS analysis of the tissue to be performed.
[0006] Once the location of the ultrasound catheter and the cannula is determined, the ultrasound catheter is withdrawn from the cannula and the cryoprobe is inserted into its location. Alternatively, the cryoprobe and cannula can be inserted directly percutaneously into the target tissue without the ultrasound catheter. In another embodiment, the cryoprobe is positioned with the aid of external ultrasound to ensure that the tip of the cryoprobe is placed with high precision into the target tissue. In some circumstances, it may be necessary to insert multiple cryoprobes into the target tissue to provide some control over the size and shape of the iceball formed by the cryoablation process.
[0007] The cryoprobe is then cooled to form an ice sphere within the patient. Ideally, the ice sphere is large enough to completely encapsulate the target tissue. To increase the effectiveness of the ice sphere in killing the target tissue, the ice sphere is frequently generated, thawed, and then the cryoprobe is re-cooled and regenerated.
[0008] The cryoprobe in the guiding cannula is then withdrawn while the ice ball is still frozen. An ultrasound catheter is inserted into the cannula and into the passage in the ice ball left by the withdrawal of the cryoprobe. Using pulse-echo techniques and beamforming, a strong signal is emitted in one radial direction from an ultrasound transducer at the end of the ultrasound catheter. The reflected ultrasound energy from the outer periphery of the ice ball is then monitored in the same direction. Using the time it takes for the ultrasound signal to return and the known speed of ultrasound in frozen tissue, the radial distance from the ultrasound transducer to the end of the ice ball in this selected direction is known. A similar signal is sent and received in another direction to generate enough information to model a slice having the same shape and size as the exact ice ball portion examined by the ultrasound beam. The ultrasound catheter can then be moved slightly within the cannula a known distance, and the process repeated to create another slice. This process is repeated long enough to calculate the slice of the entire ice ball, after which the slices are combined into a single model representing the size and shape of the ice ball.
[0009] In one embodiment, the ultrasound catheter includes an EM sensor at its tip. Using an EM navigation system, the position and orientation of the ultrasound catheter can be determined for each formed section of the ice ball model. If the EM navigation system is registered with a pre-operative CT image or model, the formed ice ball model can be superimposed on the CT image. The CT image identifies the size and location of the target tissue, making it clear whether the generated ice ball completely incorporated the target tissue within its effective treatment area. In some embodiments, the software compares the known size, shape, and location of the target tissue with the measured size, shape, and location of the generated ice ball and issues a warning if the target area is not within the treatment area of the ice ball. If necessary, a new ice ball can be generated to treat the missing part of the target area, and another model of this new ice ball can be generated to ensure the treatment effect.
[0010] Cryoablation is the only ablation technique that can measure the size, shape, and location of the tissue being ablated using these embodiments. Similar systems and methods can be used with thermal ablation, such as microwave or radiofrequency ablation. An ultrasound catheter can be inserted into the tissue to be ablated and model slices of the tissue to be ablated can be created using pulse-echo technology. Multiple slices can then be combined to create a complete model of the tissue to be ablated, and this model can be displayed on a 3D image of the target tissue to determine the effectiveness of the ablation. [Brief description of the drawings]
[0011] FIG. 1 is a side perspective view of percutaneous insertion of a cryoprobe under ultrasound guidance.
[0012] FIG. 2 is a schematic diagram of the cryoprobe of FIG. 1 penetrating target tissue and forming an ice ball.
[0013] FIG. 3 is a schematic diagram of a formed ice ball with three isotherms shown.
[0014] FIG. 4 is a schematic diagram of the formed ice ball of FIG. 3 after secondary freezing.
[0015] FIG. 5 is a schematic illustration of an irregular ice sphere formed using three cryoprobes.
[0016] FIG. 6 is a schematic diagram of the irregular ice ball of FIG. 5 as observed by standard ultrasound techniques.
[0017] FIG. 7 is a schematic diagram of the irregular ice ball of FIG. 5 with one cryoprobe withdrawn.
[0018] FIG. 8 is a schematic diagram of the irregular ice ball of FIG. 5 with an ultrasound probe inserted in place of the withdrawn cryoprobe.
[0019] FIG. 9 is a plan view of the distal end of an ultrasound probe of one embodiment within a guiding cannula.
[0020] FIG. 10 is a first diagram showing a reflected ultrasonic signal versus time.
[0021] FIG. 11 is a second diagram showing the reflected ultrasonic signal versus time.
[0022] FIG. 12 is a schematic diagram of the calculated dimensions of one slice of an ice ball.
[0023] FIG. 13 is a schematic diagram of the calculated dimensions of a multi-segment ice ball.
[0024] FIG. 14 is a flow diagram illustrating a method of practicing one embodiment of the present invention.
[0025] FIG. 15 is a schematic illustration of an irregularly shaped region of ablated tissue ablated using thermal ablation.
[0026] FIG. 16 is a plan view of the distal end of an alternative embodiment ultrasound probe within a guiding cannula.
[0027] 17 is a side perspective view of a percutaneous insertion of an ultrasound probe rotated by an electric stepper motor.
[0028] Ice ball formation Cryoablation is typically performed to kill abnormal tissue found in a patient prior to treatment. In most cases, the exact location of the abnormal tissue is identified by imaging using conventional techniques such as CT or MRI imaging. After it is determined that cryoablation is appropriate for the abnormal tissue, the patient is prepared and the abnormal tissue is again located before treatment begins. As shown in FIG. 1, an external ultrasound device 100 is used to identify the location of the target tissue. This same ultrasound device is then used to monitor the insertion of the tip of a cryoprobe 110 into a patient 120. The tip of the cryoprobe 110 may be specially designed to improve the identifiability of the tip under ultrasound, for example by fitting grooves or other physical anomalies that are highly visible to ultrasound energy. In this manner, the tip of the cryoprobe 110 is directed percutaneously to the target tissue. A further inserted ultrasound catheter may be used to identify the location of the target tissue and position the cryoprobe 110, as described below in connection with FIG. 14.
[0029] Although not shown in Figure 1, there is a computer system that determines which signals and how much power to send to the ultrasound device 100 and the cryoprobe 110, sends these signals and power to the devices 100, 110, receives signals from the devices 100, 110, analyzes these signals, and then displays the results of the analysis to the user. The computer systems that control and analyze the signals and power sent to and from the devices used in the disclosed embodiments are standard computer systems that include a CPU, short-term and long-term memory storage, computer programming, a display system, and interfaces for communicating with devices such as devices 100, 110. Computer systems such as these are also responsible for controlling the signals sent to and from the devices described below and for performing the calculation and display steps in the methods described below, including method 1400 in Figure 14.
[0030] Figure 2 shows the distal end or tip 112 of the cryoprobe 110 after the cryoprobe 110 has been inserted into abnormal target tissue 200 of a patient 120. As shown in Figure 2, the cryoprobe 110 passes through a cavity in a guiding cannula 210 that is placed in the target tissue 200. While the guiding cannula 210 is not always required for a cryoablation procedure, its use is beneficial in most embodiments of the present invention since it allows for placement of additional catheter devices in the target tissue 200.
[0031] When the tip 112 of the cryoprobe 110 is inserted into the target tissue 200, argon gas passes through the probe 110. The probe 110 is designed so that the gas expands at or near the tip 112. As argon gas expands, it cools, and this expansion causes the tip 112 of the probe 110 to cool very quickly. In a conventional cryoprobe 110, the injection of argon gas causes the tissue proximal to the tip 112 to reach a temperature of -160 to -170°C. This temperature causes an iceball 220 of frozen tissue to rapidly form adjacent the tip 112 and expand within the target tissue 200.
[0032] Although the temperature of the ice ball 220 formed near the probe may drop below -160°C, the surface temperature of the ice ball 220 remains at 0°C. It is generally known that to ensure tissue destruction, tissue must reach a temperature of -40°C or lower and be held there for approximately 3 minutes. This temperature induces ice formation within the cells, which destroys most of the cells. As a result, abnormal tissue is typically frozen for 3-5 minutes during a cryoablation procedure. At this point, the ice ball 220 has completed its growth, as shown in FIG. 3. After this time, at least half of the ice ball 220's diameter has reached a temperature of -40°C. This location is shown diagrammatically by the shaded region 300 in FIG. 3. The larger shaded region 310 indicates the approximate location of the -20°C isotherm, while the outer surface 320 of the ice ball 220 is at a temperature of 0°C.
[0033] To ensure that only that portion of the icesphere 220 exhibiting a sustained temperature of -40°C has been destroyed, most cryoablation practitioners perform this procedure twice: first by forming the icesphere 220 and then allowing it to thaw. Slow thawing of the frozen tissue within the icesphere 220 will cause further cell damage as the thawed ice crystals fuse together to form larger crystals that can cause further cell damage. This thawing process can be accelerated by passing helium through the cryoprobe 110. Unlike cryogenic gases such as argon, helium warms as it expands. As helium passes through the cryoprobe 110, it has the opposite effect to argon, warming the tip 112 of the cryoprobe 110.
[0034] Standard techniques of refreezing abnormal tissue after thawing induce a more rapid freezing of the tissue (which is more destructive to the tissue). This allows complete tissue destruction at slightly higher temperatures, such as -20°C to -30°C. As a result, the effective treatment area of the procedure moves closer to the outer periphery 320 of the ice ball 220. As shown in FIG. 4, the shaded kill area extends to approximately the -20°C isotherm 310. In most circumstances, the distance between the kill area and the ice ball periphery is expected to be 4-10 mm. Since the outer area of the ice ball 220 is outside the definitive treatment area 310, it is generally necessary to form an ice ball larger than the tissue 200 desired to be destroyed during cryosurgery.
[0035] In some situations, the ice sphere 220 needs to be formed in different shapes to match the shape and size of the target tissue 200. In this situation, multiple cryoprobes may be inserted into different parts of the tissue 200. As shown in FIG. 5, a first cryoprobes 110 is combined with a second cryoprobes 510 and a third cryoprobes 520. These two additional cryoprobes 510, 520 may be inserted into the target tissue 200 using the guide tube, but it is essential that only one probe 110 is accompanied by the outer tube 210. When the three cryoprobes 110, 510, 520 are cooled, they act together to form a single ice sphere 530 with a unitary but irregularly shaped surface 532. Some of the cryoprobes 110, 510, 520 can operate at different temperatures, with slightly higher temperatures resulting in less effective freezing. Additionally, the conditions under which the cryoprobes 110, 510, 520 are made may affect the shape of the resulting ice sphere (e.g., some probes form a more spherical morphology). By using different designs and temperatures among the cryoprobes 110, 510, 520, the resulting ice sphere 530 may be purposefully adapted to a shape that more effectively kills the target tissue 200 while minimizing damage to the surrounding tissue. As shown in FIG. 5, the resulting ice sphere 530 fails to destroy the entire target tissue 200 because a portion of the tissue 200 distal to the tip of the cryoprobe 520 may remain outside the boundary of the formed ice sphere 530. This is likely due to the third cryoprobe 520 not being inserted far enough into the target tissue 200 before forming the ice sphere 530.
[0036] The ultrasound device 100 used to guide the cryoprobes 110, 510, and 520 can be used to monitor the size and location of the iceball after its formation is complete, although the device 100 is limited in what it can view. As shown in FIG. 6, when the ultrasound device 100 is used to image the iceball 530, the ultrasonic acoustic energy 600 emanating from the device 100 passes through unfrozen tissue 620 before impacting the iceball 530. The device 100 is designed to monitor the returning ultrasonic energy. Using time and intensity information associated with this returning energy, the ultrasound imaging device can generate a three-dimensional image of the various tissues of the patient 120 into which the energy 600 has penetrated.
[0037] However, the frozen nature of the ice ball 530 makes it an extremely echogenic source for ultrasound waves 600. In fact, the difference in physical properties between thawed and frozen tissue, including changes in tissue density and the resulting changes in the speed at which sound passes through the tissue, creates an acoustic impedance mismatch that causes ultrasound energy to bounce off the ice ball. Furthermore, the ice ball itself absorbs ultrasound energy much more efficiently than non-frozen tissue. The reflective nature of the ice ball 530 allows ultrasound to form a clear image of the ice ball surface 532, but the ultrasound energy 600 cannot penetrate beyond this surface 532 efficiently. This creates an acoustic shadow behind this surface 532 that inhibits any tissue or structure behind the surface 532 from appearing in the resulting ultrasound image.
[0038] Moreover, because the ultrasonic acoustic energy 600 is emitted from a single device 100, the energy 600 essentially forms a field of view 610 that defines that portion of the ice ball surface 532 that is observed in the ultrasound image. This is true whether the device 100 utilizes a curved ultrasonic array that transmits an arc-shaped ultrasonic energy or a phased array probe that transmits a pie-shaped energy. In either case, the ultrasonic energy 600 is emitted from that single device that defines an effective field of view 610. This means that a medical practitioner using the ultrasound device 100 can view the ice ball 530 that is formed in close proximity with high accuracy, that the width of the ice ball 530 is wide enough to encompass the target tissue, and that the proximal surface 632 is located far enough out from the target tissue 200 to ensure destruction of the proximal portion of that tissue 200. However, because the medical practitioner cannot see into the shadow formed beyond the nearest surface 632 of the ice ball 530, the practitioner cannot determine whether the third cryoprobe 520 has been inserted deep enough into the target tissue 200. Ultrasound Catheter
[0039] To overcome this problem, the cryoprobe 110 may be withdrawn from the guiding tube 210 while the icesphere 530 is still frozen. The cryoprobe 110 may be initially frozen in situ, but a brief injection of helium warms the cryoprobe 110 sufficiently to allow the probe 110 to move freely without violently thawing the icesphere 530. Figure 7 shows the icesphere 530 of Figure 5 in the state in which the cryoprobe 110 has been withdrawn. As shown in this figure, withdrawal of the cryoprobe 110 leaves an opening or passageway 700 in the icesphere 530.
[0040] The fact that this passage 700 is in communication with the outer cannula 210 indicates that an ultrasound catheter 800 can be inserted into the ice sphere 530, as shown in Figure 8. This catheter 800 has a number of ultrasound transducer elements 810 at its distal end. By inserting the ultrasound catheter 800 directly into the formed ice sphere 530, the size and shape of the ice sphere 530 can be analyzed with greater precision.
[0041] Catheter 800 can be constructed according to the disclosures filed as U.S. Provisional Application Nos. 62 / 776,667 and 62 / 776,677, both of which were filed by the present applicant on December 7, 2018. The entire contents of these two provisional applications are incorporated herein by reference.
[0042] One embodiment of an ultrasound catheter 900 is shown in FIG. 9. The catheter 900 has a plurality of ultrasound transducer elements 910 near the distal end 902 of the catheter. In a preferred embodiment, a 64 element annular array of ultrasound transducer elements 910 are arranged around the periphery of the catheter 900. These transducer elements 910 may be PZT, pMUT, or cMUT based transducer elements and are capable of transmitting and detecting ultrasound energy at a variety of frequencies, such as frequencies operating between 4 and 50 MHz. Because FIG. 9 shows a plan view of the end of the ultrasound catheter 900, the individual transducer elements 910 appear to be coplanar, i.e., arranged on the flat surface of the catheter 900. While this arrangement is one possible configuration, the transducer elements 910, as in the configuration shown in FIG. 9, may be arranged around the periphery of a non-flat surface (such as an annular or cylindrical surface, such as would be formed using a catheter having a circular, elliptical, or other rounded cross-section).
[0043] The individual transducer elements 910 can form a phased array, meaning that the energy from multiple transducer elements 910 can work together to form a unidirectional beam of ultrasonic energy. This is typically done by timing the transmission of ultrasonic energy from multiple transducer elements to form an interference pattern in one controllable direction. The ultrasonic energy transmitted in that direction is greater than the amount of energy that can be transmitted from a single transducer element. The same principle operates while receiving energy by individually and carefully delaying and analyzing the reception of energy at multiple transducer elements 910 to maximize the signal that the transducer elements 910 receive from one direction. Using this approach and the annular array of transducer elements 910 shown in FIG. 9, it is possible to transmit and receive ultrasonic signals from the transducer elements 910 in one radial direction.
[0044] In some other embodiments, a synthetic aperture approach is used, where each transmit pulse is transmitted and received in an unfocused state, and a beamforming algorithm then analyzes the unfocused signal in order to focus the transmission and reception of ultrasound energy in one direction.
[0045] It is preferable to reduce the ultrasound catheter 900 to the smallest possible device size, preferably less than 2 mm in diameter, to allow for the entry of the transducer elements 910 into the passageway 700 formed by the withdrawal of the cryoprobe 110. Additionally, one embodiment is contemplated to have at least 64 imaging elements 910, although other configurations having from 16 to more than 256 elements are possible. Indeed, FIG. 16 (described below) illustrates one embodiment with only a single transducer element 1610.
[0046] In one embodiment, the ultrasound catheter 900 can generate images using conventional ultrasound imaging techniques, including a variety of suitable ultrasound imaging techniques, including grayscale "B-mode" imaging, which displays echo amplitude in the scan plane, M-mode imaging, which tracks motion at a specific fixed location over time, dual-toned power Doppler imaging, which displays motion within the scan plane, harmonic imaging, which displays nonlinear responses to incident ultrasound, elasticity imaging, which displays relative tissue stiffness, and contrast imaging, which uses contrast agents to display blood-filled spaces or targeted agents to display specific agent-bound tissue types.
[0047] A lesser known ultrasound imaging technique is based on quantitative ultrasound (QUS), which analyzes the distribution of power as a function of the frequency of the received echo signal backscattered from the tissue. QUS utilizes the resulting spectral parameters to characterize and differentiate between different tissues. QUS can be used to efficiently construct an in situ “acoustic biopsy” (AB) or “sonic biopsy” of tissue to analyze minute targeted tissue samples. QUS can also be used to analyze the properties of tumor stroma and microvasculature, providing parameters related to cell death and / or apoptosis, to provide confirmation or monitoring data for treatments such as chemotherapy, brachytherapy, cytotoxic agents (drugs), or resection. This analysis can provide intermediate feedback of tumor response to treatments, using parameters such as effective scattering diameter and effective acoustic concentration. Heterogeneity of tumor or tissue stiffness can be analyzed by evaluating the nodules from multiple different directions and by measuring the penetration depth of the ultrasound signal.
[0048] A preferred embodiment of the ultrasound catheter 900 further includes an electromagnetic (EM) sensor 920 embedded in the distal end 902. These sensors 920 can be used to guide the catheter 900 within the patient 120. In practice, at least two sensors 920 are provided adjacent to each other, but at different orientations within the catheter 900 to maximize available positional and directional information. Veran Medical Technologies has developed a series of catheter systems that use EM sensors and EM navigation to precisely target and reach minute tissue masses. This technology is detailed in U.S. Patent No. 8,696,549, entitled "Apparatus and Method for Four-Dimensional Soft Tissue Navigation in Endoscopic Applications," which is incorporated herein by reference in its entirety. This patent explains that computed tomography x-ray scans (CT scans) can often be used to build models of organs, such as lung airways, within a patient prior to surgery. Electromagnetic navigation during the procedure then uses the sensors 920 on the catheter 900 to provide positional and directional information in three-dimensional space. The 3D EM volume is registered to the CT model, allowing the catheter's position in the organ model to be displayed in real time. The Veran system also provides 4D tracking over time. It can perform under-respiratory tracking, which changes the apparent position of the probe in the virtual display to match the physical position of the EM sensor as it moves with the body's respiratory motion, a significant improvement over current devices.
[0049] In the catheter 900, the EM sensor 920 and the array of ultrasound transducer elements 910 are both coupled to an electronics package 930. This electronics package is responsible for operating the individual transducer elements 910 and for transmitting received signals along a data transmission path (not shown) through the catheter 900 for digitization analysis and display to a medical practitioner. In one embodiment, the electronics package 930 is responsible for multiplexing the signals from both the EM sensor 920 and the transducer elements 910 so that they can share a single data path along the catheter 900. Measuring ice ball size
[0050] Although the ultrasound catheter 900 is designed to produce standard ultrasound images (e.g., using B-mode imaging) and to analyze specific tissues using QUS, such imaging techniques are not used to measure the size of the ice ball 530. Due to the nature of frozen tissue, ultrasound energy transmitted through the tissue travels much more quickly than it would through normal tissue. Furthermore, the absorptive nature of frozen tissue and the risk of signal reflection before the ultrasound penetrates the ice ball make the production of a normal ultrasound image nearly impossible. Furthermore, the fact that all of the tissue in question is frozen can make it difficult to detect any differences from normal tissue visible by ultrasound.
[0051] Thus, rather than generating an image of the ice ball 530, the catheter 900 uses a pulse-echo technique that effectively operates as an ultrasound detector. The annular array of transducer elements 910 is first controlled to transmit an ultrasound signal in one direction. Multiple transducer elements 910 can be utilized to generate and transmit a single beamformed signal. Alternatively, a single transducer element 910 in the annular array can be used to transmit an ultrasound signal in that one direction. The amount of energy transmitted in this signal pulse can be greater than the amount of acoustic energy normally transmitted during imaging. In effect, this pulse-echo technique does not require fine tuning, but rather the transmitted energy needs to be maximized.
[0052] The same transducer element or elements 910 that transmit the pulses also detect the ultrasound waves after they bounce off the surface of the ice ball 530. As explained above, the impedance mismatch between the ice ball 530 and the surrounding unfrozen tissue 620 causes the ultrasound signal to be reflected when it strikes the outer periphery 532 of the ice ball 530. This reflection causes the signal to return to the transducer elements 910, where it is detected after the time it takes for the acoustic energy to travel through the ice ball 530 to the surface 532 and then return. Using the phased array technique described above, the multiple transducer elements 910 can receive this energy and filter the received energy to visualize only the energy received from the same direction as the energy was transmitted. Alternatively, the same transducer element that transmitted the signal in that direction can receive the returning energy. The peak of the received acoustic energy may be plotted against time as seen in the diagram 1000 shown in FIG. 10. The diagram 1000 shows that a large amount of ultrasonic energy is received as a peak 1010 in the diagram 1000 versus time 1012. If time 1012 is T and the speed of ultrasound through frozen ice ball 530 is V, then the total distance traveled by the sound wave received at peak 1010 is D=V*T. Since the ultrasound must travel to end 532 of ice ball 530 and return, the actual distance from catheter 900 to the end of ice ball 530 in this direction is ½V*T. Ultrasound typically travels through unfrozen tissue at approximately 1540 m / s. However, in frozen tissue, the speed of sound is much faster, between 2500 m / s and 4000 m / s. It is known that the speed of sound in frozen water increases as the temperature of the ice decreases, and this is expected to be true for frozen tissue during cryoablation treatment.
[0053] Diagram 1000 shows a somewhat idealized result of the received ultrasonic energy. In reality, it is likely that a significant portion of the ultrasonic energy transmitted from the transducer element 910 will be immediately reflected back from the initial boundary of the ice ball 530 in the passageway 700. In this case, the received ultrasonic energy may be viewed similar to diagram 1100 of FIG. 11. In this case, the outer boundary 532 of the ice ball 530 is observed as a peak 1110 at time 1112. In addition, a significant peak 1120 is observed at time 1122, which indicates an immediate reflection from within the passageway 700. This peak 1120 may be ignored when measuring the size of the ice ball 530, and may not even be detectable if it occurs too quickly after the transmission of the pulse. The ultrasonic transducer element 910 is preferably in contact with the frozen tissue of the ice ball 530 when inserted into the passageway 700. This should reduce the early reflection of the ultrasonic energy.
[0054] As explained above, the ultrasound pulse generated by the transducer element 910 is transmitted in one direction. This pulse is shown in the schematic diagram of FIG. 12 as direction 1200. Using a time analysis of diagrams 1000 / 1100 and the equations above, the distance from the catheter 900 to the outer wall 532 of the ice ball 530 can be calculated. Once this pulse occurs, the transducer element 910 transmits another pulse in a different direction, such as direction 1210, and then measures the distance to the outer boundary 532 in that direction 1210. This is repeated in a third direction 1220, and then across the full 360° range of the transducer element 910. In each direction, the distance to the outer boundary 532 is measured from a known position of the catheter 900 (position 1202 in FIG. 12). When these distances are combined as shown in FIG. 12, a segment 1230 is formed that indicates the size and shape of the ice ball's perimeter 532. In this embodiment, each pulse is transmitted radially from transducer element 910 of catheter 900 (position 1202), meaning that the resulting slice 1230 only represents the size of ice ball 530 at the current position of transducer element 910.
[0055] The process of physically sliding the catheter 900 within the guide tube 210 to form segments 1230 at various locations within the ice sphere 530 can be repeated. In one embodiment, the catheter 900 is started at the furthest location within the passageway 700 and then moved 2-10 mm for each segment (e.g., segment 1230) formed along the passageway 700. When these segments are combined, a relatively complete model 1300 of the size and shape of the ice sphere 530 is formed, as shown in FIG. 13. To form these various segments, the catheter 900 is moved along a path shown as element 1302 in FIG. 13 relative to the passageway 700 and the guide tube 210. Note that the outer wall 532 of the ice sphere 530 may not be centered around the passageway 700 formed by the cryoprobe 110, and therefore this path 1302 is not the "axis" or "center point" of the segments that make up the model 1300.
[0056] As described above, the physical location of the catheter tip 902 can be identified at any time using EM navigation and signals generated by the EM sensor 920. The resulting 3D model 1300 of the ice ball 530 can be located in 3D space and then overlaid on the recorded CT image showing the target tissue 200. Using this approach, the medical practitioner can identify areas where the dead area of the ice ball 530 failed to encompass the target tissue 200. In some embodiments, the model of the target tissue 200 in the CT image is automatically compared to the 3D model 1300 of the ice ball 530 to automatically alert the medical practitioner to the target tissue 200 remaining outside the effective area of the ice ball 530. With this feedback, the medical practitioner may reinsert the cryoprobe 110 to refreeze the tissue using the existing position of the probe 110, 510, 520 by using a longer or more intense freezing cycle. Alternatively, the medical practitioner may insert additional probes to treat the unfrozen areas of the target tissue 200. Process 1400
[0057] The individual steps described above can be combined into a process or method 1400 as shown in the flow diagram of FIG. 14. The first step 1405 in this process is the only step that differs significantly from the steps described above. In connection with FIG. 1 and FIG. 2, this step was described as an ultrasound device 100 can assist in guiding the cryoprobe 110 into the target tissue 200. In another embodiment, the EM sensor 920 of the ultrasound catheter 900 can be directed to the target tissue 200 using EM navigation. Once the ultrasound transducer 910 is positioned in the (unfrozen) target tissue 200, an image of the tissue 200 can be acquired. In one embodiment, QUS is used to assist in diagnosing or otherwise analyzing the target tissue. In step 1405, the ultrasound image formed by the sensor 910 can be used to ensure that the guide tube 210 is properly positioned for the insertion of the cryoprobe 110. In step 1410, the ultrasound catheter 900 is withdrawn, and in step 1415, the cryoprobe 110 is inserted through the guide tube 210 to the same location. Optionally, additional cryoprobes 510, 520 may be inserted into the target tissue 200 to form an iceball 530 of appropriate size and shape.
[0058] In step 1420, the cryoprobe is used to freeze the target tissue, and as explained above, the freezing process often includes two distinct freezing operations separated by a thawing operation of the ice balls 530 to improve the effectiveness of the ice balls 530.
[0059] At step 1425, the cryoprobe 110 is withdrawn, thereby creating a passageway within the ice globe 530 accessible through the guiding tube 210. At step 1430, the ultrasound catheter 900 is inserted into this passageway.
[0060] The ultrasound catheter 900 is then used to create a 3D model of the ice ball size. This creation is performed by steps 1435-1455 of method 1400. In step 1435, a direction is selected in which to transmit a pulse of ultrasound energy. Echoes from the outer edge 532 of the ice ball 530 are then detected in that direction. The known speed of ultrasound in frozen tissue is then used to determine the distance from the catheter 900 to the outer edge 532 in that direction. This is then repeated at various angles until the size and shape of the ice ball 530 fragment is determined in step 1440. The ideal angle between each pulse is determined using laboratory testing to provide a good compromise between the increased detail of the fragment model obtained by a small angle between pulses and the speed of model creation obtained by using a larger angle between pulses. As computational techniques improve the speed of analysis of each pulse increases, the preferred angle will decrease. In one embodiment, the angle between pulses is selected to be between 5° and 20°. In step 1445, steps 1430-1445 are repeated, moving catheter 900 to form multiple slices, each slice representing the shape and size of iceball 530 at that position along the path of catheter 900 movement (step 1450). These multiple slices are then combined into a single 3D model of iceball 530 in step 1455.
[0061] Catheter 900 includes EM sensor 920, allowing for the positioning, sizing, and orientation of the 3D model within the CT images used for EM navigation. In step 1460, the 3D model is displayed on these images.
[0062] In step 1465, any portions of the target tissue 200 that appear to have missed the effectiveness of the modeled ice ball 530 are determined. This determination can be accomplished using computer software that compares the size, shape, and orientation of the 3D model to the known size, shape, and orientation of the target tissue 200. Since both the 3D model and the target tissue can be displayed simultaneously on the display, some distinguishable visual characteristic can be used to indicate the surviving portions of the target tissue. For example, the surviving tissue may be displayed with a unique color or with a different (lighter or darker) intensity than the surrounding tissue. Whatever characteristic is used, it is important that the medical practitioner can immediately see and identify which portions of the target tissue are not included within the dead zone of the modeled ice ball 530. This surviving tissue can be treated in step 1470. In some cases, the entire process 1405-1465 can be repeated by step 1470 to determine that all of the target tissue 200 has been destroyed. In other cases, the method of altering the size and shape of the ice ball 530 to effectively freeze the surviving target tissue simply requires refreezing one or more of the cryoprobes 110, 510, 520. The method then ends at step 1475. Application of thermal ablation
[0063] The novel process of visualizing the ablated tissue described above has applications beyond cryosurgery. Targeted tissue can be ablated by a variety of techniques, including microwave ablation and radiofrequency ablation. In microwave ablation, electromagnetic waves in the microwave range (300 MHz-300 GHz) are applied to kill tissue in a target area. Water in the tissue absorbs the microwave radiation, thereby heating and killing the tissue. Radiofrequency ablation is similar, using electromagnetic waves (in this case in the radiofrequency range) to heat and kill the targeted tissue. In both cases, the electromagnetic waves are transmitted by a needle that is inserted directly into the target tissue. This needle is coupled with a cryoprobe 110 and navigated to the target tissue in the same manner as described above, and then a heat-generating signal is emitted from the end of the needle. This means that the needle can be inserted percutaneously, laparoscopically, or intraoperatively. In both cases, the needle can be inserted into the target tissue using a guiding intubation, such as the intubation tube 210 described above.
[0064] To apply the above technique in a thermal ablation context, an RF or microwave ablation needle 1510 is inserted into the target tissue 1500 through a guide tube 1520. In a microwave ablation context, additional microwave needles 1512, 1514 can be inserted into the target tissue 1500 to conform to the resulting shape of the ablation area 1530. It is generally not possible to activate multiple radiofrequency ablation needles at the same time. Nevertheless, it is still possible to treat multiple ablation source locations with radiofrequency ablation by inserting multiple identical ablation needles or by using different needles while ensuring that no two needles are activated at the same time. Regardless of whether multiple needles or multiple insertions are used, multiple ablation source locations are used to create irregularly shaped areas of ablated tissue 1530.
[0065] As explained above, the physician performing the ablation procedure needs to know whether the area of dead / ablated tissue 1530 has successfully killed the target tissue 1500 in the patient. To determine this, the ablation needle 1510 inserted through the guiding tube 1510 is withdrawn and an ultrasound catheter is inserted through the same guiding tube 1510 into the central portion of the ablated tissue 1530. Using the same techniques as described above, the size, shape, location, and orientation of the ablated tissue 1530 relative to the target tissue 1500 can be determined. Of course, the above calculations are slightly modified since the ablated tissue 1530 is heated instead of frozen. It is known that ultrasound energy travels much faster through frozen tissue than normal tissue, and as a result, it is difficult to image a frozen ice ball in three dimensions using standard ultrasound imaging techniques. It is also true that the manner in which ultrasound energy passes through heated ablated tissue 1530 is very different, which makes it even more difficult to image the ablated tissue 1530 using standard ultrasound techniques. Using pulse-echo techniques and beamforming, and modifying the algorithm described above to use the velocity of ultrasonic energy in the heated ablated tissue rather than the velocity in the ice ball, it is possible to generate a model of the ablated tissue 1530 and compare this model to the size and location of the target tissue 1500. As described above in connection with cryotherapy, this process can determine if the heated ablated tissue 1530 failed to encompass all of the target tissue 1500, resulting in the physician performing another RF or microwave ablation procedure to ensure adequate treatment of the portions of the target tissue 1500 that were outside of the original thermal ablation area 1530. Single transducer catheter
[0066] Another embodiment ultrasound catheter 1600 is shown in FIG. 16 with only a single transducer element 1610 proximal to the tip 1602 of the catheter 1600. A larger single transducer element 1610 would be used to maximize the amount of ultrasound energy transmitted perpendicular to the transducer element 1610. The same large transducer element 1610 would also be more sensitive in receiving ultrasound energy reflected from the distal boundary 532 of the ice ball 530. This single transducer element pulsing in one direction makes the ultrasound catheter 1600 optimal for the sonar-like pulses required to perform the method 1400 described above.
[0067] The transducer elements 1610 are preferably flat, and in one embodiment, the transducer elements are located on a flat surface 1620 at the tip of the ultrasound catheter 1600. The flat surface 1620 may extend the entire length of the catheter 1600, or the surface may terminate at a location 1622 as in FIG. 16. The location 1622 separates the tip section with the flat surface 1620 from the remaining portion 1630 of the catheter 1600. The remaining portion 1630 may therefore be of circular or nearly round cross-section to facilitate movement within the guide catheter 210. The cross-section of the tip section with the flat surface 1620 may be semicircular with a rounded base (not shown) at the apex of which the flat surface 1620 that holds the transducer element 1610 is located.
[0068] 16, the catheter 1600 may also include embedded electromagnetic (EM) sensors 1640 at the distal end 1602. These EM sensors 1640 function as described above in conjunction with the sensor 920. An electronics package 1642 is coupled to the single transducer element 1610 and the EM sensor 1640 to control the signals transmitted and received from these components.
[0069] The use of an ultrasound catheter carrying a single transducer element 1610 allows for greater energy transfer in one direction as well as better signal detection. The use of a single transducer element 1610 significantly reduces the ability of the catheter 1600 to generate ultrasound images, but this reduction in functionality is not significant in the context of the method 1400. However, due to the absence of an annular array of transducer elements 910 utilized in the catheter 900, the single transducer element catheter 1600 must be rotated to form the above-described slices (such as slice 1230). This rotation can be performed manually by a medical practitioner in the same manner that a medical practitioner rotates any other catheter. The need for a 360° rotation to be performed manually highlights the importance of high accuracy position measurement that is only available through the use of the EM sensor 1640. Manual rotation of the catheter 1600 by a medical practitioner can cause inadvertent translational movement of the catheter 1600 relative to the guiding catheter 210. Such inadvertent position changes can be recorded by detecting the position of the EM sensor 1602. The exact current position of catheter 1600 for each angular distance measurement (step 1435) may not allow for isomorphic "slices" to be formed, but a highly accurate overall model equivalent to ice ball 530 can be formed.
[0070] Another embodiment is shown in FIG. 17, which shows a single transducer catheter 1600 in use with a patient by inserting the catheter through a guide tube 210. An electric stepper motor 1700 is attached to the catheter 1600. The stepper motor is physically coupled to the catheter 1600 such that the motor 1700 can control the rotation of the catheter 1600. Each step of the motor 1700 is associated with a rotation of the catheter through a given angle, so that a control signal can be sent along control wiring 1710 to cause the motor 1700 to rotate the catheter 1600 as required and as commanded. In this way, the medical practitioner does not have to manually rotate the catheter 1600. Instead, the motor 1700 under the control of control wiring 1710 can time the rotation of the single transducer element 1600 such that the translational movement of the transducer element 1600 during the rotation cycle is minimized so that measurements of the entire slice of the ice ball 530 are performed as quickly and efficiently as possible.
[0071] The many features and advantages of the present invention are apparent from the above description. Numerous modifications and variations will readily occur to those skilled in the art. Because of the potential for such modifications, the present invention is not limited to the exact construction and operation as illustrated and described. Rather, the present invention is to be limited only by the scope of the following claims.
Claims
1. 1. A method for cryoablation, comprising: a) inserting a cryoprobe through a guiding tube into a target tissue of a patient; b) cooling the distal end of the cryoprobe to form an ice ball at the distal end of the cryoprobe; c) withdrawing the cryoprobe from the guiding tube; d) inserting an ultrasound catheter having an ultrasound transducer at its distal end into the guiding tube; e) transmitting a directional ultrasonic signal from within the ice ball using the ultrasonic transducer and monitoring the ultrasonic transducer for ultrasonic reflections from a surface of the ice ball; f) calculating the distance from the ultrasound catheter to the surface of the ice ball based on the time required to receive the ultrasound reflection and the speed of ultrasound in the frozen tissue; g) repeating steps e) and f) in various directions to generate sufficient information to form segments of said ice ball; h) moving the ultrasound catheter a known distance within the cannula; i) repeating steps e) through h) to calculate a plurality of segments of at least a portion of the ice ball; and j) combining, using a computer, the plurality of sections into an ice ball model representative of the size and shape of the ice ball portion.
2. k) using said computer to determine an effective treatment area for said ice ball; and 10. The method of claim 1, further comprising: l) using the computer to compare the ice ball model to a known size and shape of the target tissue to identify portions of the target tissue that are outside of an effective treatment area of the ice ball.
3. 3. The method of claim 2, further comprising the step of: m) repeating steps a) through j) on portions of the target tissue outside of the effective treatment area of the ice ball.
4. 1. A method for treating a patient, comprising: a) inserting an ablation catheter into a target tissue of the patient through an guiding cannula; b) ablating the target tissue with the ablation catheter to form a region of ablated tissue having a known ultrasound propagation velocity that is different from the normal ultrasound propagation velocity in unablated tissue; c) withdrawing the ablation catheter and inserting the ultrasound catheter into the guiding cannula such that at least one ultrasound transducer element at a distal end of the ultrasound catheter is positioned within the ablation tissue; d) transmitting a plurality of directional ultrasound pulses radially from the ultrasound catheter into the ablated tissue; e) using a computer to measure a plurality of distances from the ultrasound catheter to the edge of the region of ablated tissue by using the time between transmission and reception of each pulse and using the known speed of ultrasound transmission in the region of ablated tissue; and f) using the computer to generate a model of the region of ablated tissue using the radially measured distances and translational positions of each pulse, the plurality of directional ultrasound pulses including: i) individually directed in a particular radial direction from said ultrasound catheter and received from said particular radial direction; ii) are transmitted collectively in multiple radial directions; and iii) collectively transmitted by said ultrasound catheters positioned at a plurality of different said translational positions relative to said guide intubation.
5. 5. The method of claim 4, further comprising the step of: g) using the computer to display a model of the area of ablated tissue on a three-dimensional image of the patient showing the target tissue.
6. h) comparing, on the computer, the model of the ablated tissue region against the known size and shape of the target tissue to identify portions of the target tissue that are outside of an effective treatment area of the ablated tissue region; and The method of claim 5, further comprising the step of: i) displaying the identified portion of the target tissue using a distinguishable visual characteristic.
7. The method of claim 5, wherein the distal end of the ultrasound transducer further comprises an electromagnetic sensor that receives electromagnetic signals that position the distal end within an electromagnetic field, and further comprises using the received electromagnetic signals to display a model of the area of the resected tissue on a three-dimensional image of the patient.
8. The method of claim 4 , wherein the ablation catheter is a cryoprobe and further wherein the region of ablated tissue comprises an ice ball.
9. 5. The method of claim 4, wherein the ablation catheter is a heated ablation catheter, and further wherein the region of ablated tissue comprises thermally killed tissue.
10. The method of claim 9 , wherein the heated ablation catheter is a microwave ablation catheter.
11. The method of claim 9 , wherein the heated ablation catheter is a radiofrequency ablation catheter.
12. 5. The method of claim 4, wherein the ultrasound catheter has a plurality of ultrasound transducer elements at the distal end, and wherein each ultrasound pulse is generated using a subset of less than all of the ultrasound transducer elements, and wherein the subset is selected based on a particular radial direction of each ultrasound pulse.
13. The method of claim 12 , wherein the plurality of ultrasound transducer elements are arranged in an annular array about a circumference of the ultrasound catheter at a distal end of the ultrasound catheter.
14. The method of claim 13 , wherein the subset of ultrasonic transducer elements form phased array transmit elements that transmit each directional ultrasonic pulse.
15. 15. The method of claim 14, wherein a subset of the same ultrasonic transducer elements that form the phased array transmit elements also form phased array receive elements that receive each directional ultrasonic pulse.
16. The method of claim 13 , wherein the subset of ultrasonic transducer elements form a phased array receive element that receives each directional ultrasonic pulse.
17. 5. The method of claim 4, wherein the ultrasound catheter has a single ultrasound transducer element at the distal end, the single ultrasound transducer element transmitting and receiving directional ultrasound pulses.
18. 20. The method of claim 17, wherein the ultrasound catheter and the single ultrasound transducer element are physically rotated to transmit multiple ultrasound pulses in multiple radial directions.
19. 20. The method of claim 18, wherein an electric stepper motor physically rotates the ultrasound catheter.
20. 1. A method for treating a patient, comprising: a) inserting an ultrasound catheter located within a guiding tube into a target tissue of the patient; b) performing a QUS analysis on the target tissue using the ultrasound catheter; c) replacing the ultrasound catheter with a cryoprobe without moving the guiding tube; d) cooling the cryoprobe to form an ice ball; e) replacing the cryoprobe with the ultrasound catheter without moving the guiding tube; and f) using the ultrasound catheter to generate ultrasonic energy within the ice ball and measure the distance between the ultrasound catheter and a periphery of the ice ball.
Citation Information
Patent Citations
Apparatus and method for coordinated insertion of multiple cryoprobes
JP2009524469A
Interstitial microwave system and method for thermal treatment of diseases
US20070185554A1
Cryptographically secure financial instruments
US20180204284A1
Cryotherapy element and cryotherapy device
WO2012017731A1
